Non‐alcoholic fatty liver disease (NAFLD) may vary from moderately mild non‐alcohol fatty
liver (NAFL) towards the malignant variant known as non‐alcoholic steatohepatitis (NASH) …

The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide;
however, there are currently limited treatments for NAFLD. The disease spectrum includes …

The liver is a crucial organ that is involved in various kinds of metabolic activity and a very
stable accessory gland for the digestive system. Long‐term or persistent inflammation and …

The role of flavonoids as the major red, blue and purple pigments in plants has gained these
secondary products a great deal of attention over the years. Flavonoids are polyphenols and …

The liver controls the body's internal environment via various physiological and metabolic
processes, either independently or together with other organs. Liver disease is defined as …

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
is one of the most common chronic liver diseases, which may progress to fibrosis, cirrhosis …

Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …

The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD)
comprises multiple parallel pathways with a dynamic cross talk that cumulate in steatosis …

Background: Flavonoids are a class of polyphenolic bioactive compounds obtained from
plants, which have a wide range of chemical structures and properties. More than 9000 …

Flavonoids are naturally occurring compounds that show health benefits on the liver.
However, there is little investigation about identification and evaluation of new flavonoid …